Following this observation, we did a meta-analysis of mDCs and HLA-DR+CD4+ pDCs in PBMCs from prostate cancer (PC) and ovarian cancer (OvCa) patients and frequencies were compared to those identified in healthy donors (HD) (Supplementary Figure 2). Here, CD4 is linked to ovarian cancer.